Inovio Pharmaceuticals Gets New Funding

Inovio Pharmaceuticals Gets New Funding

Inovio Pharmaceuticals said Tuesday the International Vaccine Institute (IVI) will provide new funding and support to further advance research on the company’s vaccine to prevent the Middle East Respiratory Syndrome (MERS) virus infection. Shares drifted slightly lower intraday. Inovio is co-developing the vaccine with GeneOne Life Science, it said in a statement. IVI will add technical, laboratory and financial support for GLS-5300 clinical trials in Korea. The company said the […]

Read More ˃
CACI Wins Five-Year Intelligence Service Order

CACI Wins Five-Year Intelligence Service Order

CACI International, which provides information technology services for governments and intelligence services, won a five-year task order, with a ceiling value of $1.77 billion, from the Joint Improvised-Threat Defeat Organization (JIDO). CACI said it will provide deployable analytical operations, integrated intelligence, and training services to the organization, it said on Monday. The anticipated spend is estimated at $875.6 million, which the company will be recording as an increase to its […]

Read More ˃
Sarepta Therapeutics Up 1.5%

Sarepta Therapeutics Up 1.5%

Sarepta Therapeutics is up 1.5% after Aetna (AET) released a new clinical policy bulletin describing the conditions under which it deems Sarepta’s Duchenne muscular dystrophy drug Exondys 51 is medically necessary. Aetna said it deemed the drug medically necessary when “1) member has a confirmed mutation of the DMD gene amenable to exon 51 skipping; 2) eteplirsen has been initiated in childhood (before 14 years of age); 3) member is […]

Read More ˃
Royal Dutch Shell Gains 4%

Royal Dutch Shell Gains 4%

Royal Dutch Shell is up 4% after Centrica said it agreed to sell gas assets in Trinidad and Tobago for $30 million to Royal Dutch Shell. The assets include a 17.3% interest in the producing NCMA-1 block as well as operating interests in two undeveloped blocks and 80% and 90% operated interests respectively in the undeveloped blocks NCMA-4 and Block 22, Centrica said. Centrica also will receive further payments subject […]

Read More ˃
Nutanix Fiscal Q1 Earnings, Revenue Beat Estimates

Nutanix Fiscal Q1 Earnings, Revenue Beat Estimates

Nutanix reported earnings for fiscal 2017 Q1 were at a loss of $0.37 per share, beating out the Street consensus of a loss of $0.44 per share but widening from a loss of $0.27 a year earlier. Revenue for the quarter came in higher than analysts projected at $166.8 million versus $152.3 million, and was up 90.1% year-over-year from $87.8 million. The company also established guidance for fiscal Q2, saying […]

Read More ˃
Mixed Finish for Consumer Stocks on ‘Cyber Monday’

Mixed Finish for Consumer Stocks on ‘Cyber Monday’

Consumer stocks were ending mixed to begin the new week, with shares of consumer staples companies in the S&P 500 rising about 0.2% while shares of consumer discretionary firms in the S&P 500 slid 0.8% lower. In company news, Hasbro (HAS) declined on Monday after analysts at Piper Jaffray today pared their investment rating for the company’s stock to Neutral from Overweight. HAS shares were down almost 3% at $85.36 […]

Read More ˃